Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcoma.
Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcoma.
复制标题
癌症基因的下一代靶向测序发现了平滑肌肉瘤中常见的 TP53 和 ATRX 突变。
DOI:
--
复制
发表时间:
2015
影响因子:
2.2
通讯作者:
Y. Jeng
中科院分区:
文献类型:
--
作者:
Ching;Jau;Wei;Yu;Ming‐Chu Chang;Jen;J. Tsai;Yidi Su;Chia;Y. Jeng
Leiomyosarcoma is an aggressive soft tissue sarcoma with poor patient survival. The genetic changes of leiomyosarcoma remain to be discovered. In this study, we analyzed the genetic changes of 44 cancer-related genes by using next-generation sequencing in 54 leiomyosarcomas. We identified TP53 mutations in 19 of the 54 tumors (35%) and ATRX mutations in 9 of the 54 tumors (17%). The TP53-mutated leiomyosarcomas were limited to female patients (P = 0.006). All but 2 of the TP53-mutated leiomyosarcomas were located in the uterus (n = 11) or retroperitoneum (n = 6). The ATRX mutations were associated with poorly differentiated leiomyosarcomas (P = 0.028) and the presence of tumor necrosis (P = 0.015). Kaplan-Meier survival analysis showed that patients with ATRX-mutated leiomyosarcomas had worse overall survival than did patients with ATRX-wild-type leiomyosarcomas. All of the ATRX-mutated leiomyosarcomas showed the alternative lengthening of telomere phenotype. The ATRX mutations did not correlate with ATRX protein expression, as detected using immunohistochemistry. In conclusion, we identified loss of function of the p53 and ATRX pathways being the main mechanisms for leiomyosarcomas. The molecular mechanisms may provide new opportunities to treat these aggressive neoplasms.
DOI:
--
发表时间:
1994
期刊:
The American journal of pathology
影响因子:
--
作者:
Latres,E;Drobnjak,M;Pollack,D;Oliva,MR;Ramos,M;Karpeh,M;Woodruff,JM;Cordon-Cardo,C
通讯作者:
Cordon-Cardo,C
影响因子:
10.5
作者:
PAVLETICH, NP;CHAMBERS, KA;PABO, CO
通讯作者:
PABO, CO
影响因子:
45.3
作者:
Hensley, ML;Maki, R;Spriggs, DR
通讯作者:
Spriggs, DR